
Fred L. Braun
Examiner (ID: 8458)
| Most Active Art Unit | 2105 |
| Art Unit(s) | 2107, 2102, 2852, 2105, 2101 |
| Total Applications | 2150 |
| Issued Applications | 1833 |
| Pending Applications | 19 |
| Abandoned Applications | 298 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3732041
[patent_doc_number] => 05665705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'Glucagon analogs with serine replacements'
[patent_app_type] => 1
[patent_app_number] => 8/473334
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4730
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 344
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665705.pdf
[firstpage_image] =>[orig_patent_app_number] => 473334
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473334 | Glucagon analogs with serine replacements | Jun 6, 1995 | Issued |
Array
(
[id] => 3850643
[patent_doc_number] => 05767087
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Pharmaceutical preparation for the therapy of immune deficiency conditions'
[patent_app_type] => 1
[patent_app_number] => 8/486044
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3675
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767087.pdf
[firstpage_image] =>[orig_patent_app_number] => 486044
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/486044 | Pharmaceutical preparation for the therapy of immune deficiency conditions | Jun 6, 1995 | Issued |
Array
(
[id] => 3833216
[patent_doc_number] => 05814611
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Pharmaceutical for the therapy of immune deficiency conditions'
[patent_app_type] => 1
[patent_app_number] => 8/482121
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3680
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814611.pdf
[firstpage_image] =>[orig_patent_app_number] => 482121
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/482121 | Pharmaceutical for the therapy of immune deficiency conditions | Jun 6, 1995 | Issued |
Array
(
[id] => 3850629
[patent_doc_number] => 05767086
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Bone marrow stimulation by certain glutathione analogs'
[patent_app_type] => 1
[patent_app_number] => 8/482645
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 5384
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767086.pdf
[firstpage_image] =>[orig_patent_app_number] => 482645
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/482645 | Bone marrow stimulation by certain glutathione analogs | Jun 6, 1995 | Issued |
Array
(
[id] => 3687738
[patent_doc_number] => 05643868
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'Method of treating or preventing type 1 diabetes by oral administration of insulin'
[patent_app_type] => 1
[patent_app_number] => 8/472016
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5271
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/643/05643868.pdf
[firstpage_image] =>[orig_patent_app_number] => 472016
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472016 | Method of treating or preventing type 1 diabetes by oral administration of insulin | Jun 5, 1995 | Issued |
Array
(
[id] => 3704224
[patent_doc_number] => 05674976
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Conformationally restricted mimetics of gamma turns and peptides containing the same'
[patent_app_type] => 1
[patent_app_number] => 8/486281
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4574
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/674/05674976.pdf
[firstpage_image] =>[orig_patent_app_number] => 486281
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/486281 | Conformationally restricted mimetics of gamma turns and peptides containing the same | Jun 5, 1995 | Issued |
Array
(
[id] => 3723191
[patent_doc_number] => 05670155
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-23
[patent_title] => 'Confomationally restricted mimetics of beta turns and beta bulges and peptides containing the same'
[patent_app_type] => 1
[patent_app_number] => 8/473401
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9253
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/670/05670155.pdf
[firstpage_image] =>[orig_patent_app_number] => 473401
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473401 | Confomationally restricted mimetics of beta turns and beta bulges and peptides containing the same | Jun 5, 1995 | Issued |
Array
(
[id] => 3697088
[patent_doc_number] => 05618914
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-08
[patent_title] => 'Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same'
[patent_app_type] => 1
[patent_app_number] => 8/484060
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4577
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/618/05618914.pdf
[firstpage_image] =>[orig_patent_app_number] => 484060
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484060 | Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same | Jun 5, 1995 | Issued |
Array
(
[id] => 3686524
[patent_doc_number] => 05696001
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-09
[patent_title] => 'Fluorogenic compounds and their use'
[patent_app_type] => 1
[patent_app_number] => 8/466014
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2990
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/696/05696001.pdf
[firstpage_image] =>[orig_patent_app_number] => 466014
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466014 | Fluorogenic compounds and their use | Jun 5, 1995 | Issued |
Array
(
[id] => 3725034
[patent_doc_number] => 05672681
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-30
[patent_title] => 'Conformationally restricted mimetics of gamma turns and peptides containing the same'
[patent_app_type] => 1
[patent_app_number] => 8/485463
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9202
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/672/05672681.pdf
[firstpage_image] =>[orig_patent_app_number] => 485463
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/485463 | Conformationally restricted mimetics of gamma turns and peptides containing the same | Jun 5, 1995 | Issued |
Array
(
[id] => 3659336
[patent_doc_number] => 05648229
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'Fluorogenic compounds and their use'
[patent_app_type] => 1
[patent_app_number] => 8/466018
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2992
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648229.pdf
[firstpage_image] =>[orig_patent_app_number] => 466018
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466018 | Fluorogenic compounds and their use | Jun 5, 1995 | Issued |
Array
(
[id] => 3659560
[patent_doc_number] => 05667784
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-16
[patent_title] => 'Tocols as adjuvant in vaccine'
[patent_app_type] => 1
[patent_app_number] => 8/463331
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3191
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/667/05667784.pdf
[firstpage_image] =>[orig_patent_app_number] => 463331
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463331 | Tocols as adjuvant in vaccine | Jun 4, 1995 | Issued |
| 08/464398 | MULTICATALYTIC PROTEASE INHIBITORS | Jun 4, 1995 | Abandoned |
Array
(
[id] => 3662635
[patent_doc_number] => 05667992
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-16
[patent_title] => 'Mammalian expression systems for HCV proteins'
[patent_app_type] => 1
[patent_app_number] => 8/453552
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20617
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/667/05667992.pdf
[firstpage_image] =>[orig_patent_app_number] => 453552
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/453552 | Mammalian expression systems for HCV proteins | May 29, 1995 | Issued |
Array
(
[id] => 3518084
[patent_doc_number] => 05506202
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-09
[patent_title] => 'Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them'
[patent_app_type] => 1
[patent_app_number] => 8/442296
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6157
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/506/05506202.pdf
[firstpage_image] =>[orig_patent_app_number] => 442296
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/442296 | Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them | May 15, 1995 | Issued |
Array
(
[id] => 3646781
[patent_doc_number] => 05683907
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-04
[patent_title] => 'Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/435603
[patent_app_country] => US
[patent_app_date] => 1995-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11552
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/683/05683907.pdf
[firstpage_image] =>[orig_patent_app_number] => 435603
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/435603 | Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies | May 4, 1995 | Issued |
| 08/417478 | MAMMALIAN EXPRESSION SYSTEMS FOR HCV PROTEINS | Apr 4, 1995 | Abandoned |
Array
(
[id] => 3856646
[patent_doc_number] => 05705483
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-06
[patent_title] => 'Glucagon-like insulinotropic peptides, compositions and methods'
[patent_app_type] => 1
[patent_app_number] => 8/407831
[patent_app_country] => US
[patent_app_date] => 1995-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6776
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/705/05705483.pdf
[firstpage_image] =>[orig_patent_app_number] => 407831
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/407831 | Glucagon-like insulinotropic peptides, compositions and methods | Mar 20, 1995 | Issued |
Array
(
[id] => 3588944
[patent_doc_number] => 05550183
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-27
[patent_title] => 'Metal-peptide compositions and methods for stimulating hair growth'
[patent_app_type] => 1
[patent_app_number] => 8/401648
[patent_app_country] => US
[patent_app_date] => 1995-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 7799
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/550/05550183.pdf
[firstpage_image] =>[orig_patent_app_number] => 401648
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/401648 | Metal-peptide compositions and methods for stimulating hair growth | Mar 6, 1995 | Issued |
Array
(
[id] => 3553704
[patent_doc_number] => 05519001
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-21
[patent_title] => 'CETP inhibitor polypeptide antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments'
[patent_app_type] => 1
[patent_app_number] => 8/394066
[patent_app_country] => US
[patent_app_date] => 1995-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9718
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/519/05519001.pdf
[firstpage_image] =>[orig_patent_app_number] => 394066
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/394066 | CETP inhibitor polypeptide antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments | Feb 23, 1995 | Issued |